An interventional study of Resistance Exercise Therapy in Bariatric Surgery Candidate and Obesity, sponsored by University of Nottingham. Recruiting at 1 site in United Kingdom. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2024-06-20.
Sponsored by University of Nottingham · Not applicable, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 21 studies in Obesity by University of Nottingham — 5 open to participants now, 5 under way, none of them phase 3. Obesity · University of Nottingham.
Among the 21 studies in Obesity by University of Nottingham, this one is the 12th largest by planned enrollment of the 17 interventional ones that give a count, is the only one that started in 2023, is one of 15 with no phase, and was the 17th registered.
11,564 studies on the registry are indexed under Obesity; 2,063 are open to participants now.
Browse Obesity studies →5 of the 21 studies in Obesity by University of Nottingham are open now, in 1 country. Recruiting first, the newest first:
University of Nottingham · Sites in United Kingdom
Ages 18–65
University of Nottingham · Sites in United Kingdom
Ages 18+
University of Nottingham · Sites in United Kingdom
Ages 18–65 · Healthy volunteers
University of Nottingham · Sites in United Kingdom
Ages 18–70
By country, each count listing its studies:
Of the 1,352 Obesity studies recruiting now, 382 (28%) set no upper age limit and 867 (64%) stop at 75 or younger; 169 take children under 18; 491 take healthy volunteers.
This study: 18 Years to 70 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
21 studies; the count open now beside each. This study's row is marked.
First in 2008; this study’s year is marked. 1 started in 2023.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 12 is below the median of 67 across 9,043 interventional studies indexed under Obesity.
Median enrollment 24 across the 17 interventional studies, 50 across the 4 observational. Of the 13 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
University of Nottingham is the lead sponsor of 465 studies on the registry; 80 are open to participants now.
2 of the studies in Obesity by University of Nottingham that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07565935University of NottinghamEffects of HIIT Following PTR Programme | 2027-01 |
| NCT07652320University of NottinghamGlycaemic Response of Arabic Bread | 2027-03-31 |
Add all 2 to your calendar (.ics) → With an account.
Among the 21 studies in Obesity by University of Nottingham, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The purpose of this project is to assess the effects of bariatric surgery on muscle structure and function as well as investigating the feasibility of undertaking an exercise intervention post-surgery.
A single-centre feasibility research programme based at the Royal Derby Hospital centre of the University of Nottingham. This is an exploratory and feasibility study. Muscle structure and function of 12 patients will be assessed before bariatric surgery and at 6 weeks, and then 10 weeks, after surgery. After 6 weeks, participants will be randomised into two groups. Group 1 will undergo a 4 week Resistance Exercise Training (RET). Group 2 will undergo standard care procedure. The total duration of programme we are aiming for is 13-14 weeks prior to bariatric surgery and exercise intervention for 4 weeks after bariatric surgery.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
The New York Heart Association’s four classes of how much heart failure limits physical activity.
Studies set their own limit — many outside heart failure leave out class III–IV, while heart failure studies may ask for a particular class. Check the class this study names.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
NYHA class (heart failure)
The New York Heart Association’s four classes of how much heart failure limits physical activity.
Studies set their own limit — many outside heart failure leave out class III–IV, while heart failure studies may ask for a particular class. Check the class this study names.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
One group who have been randomised to receive 4 weeks of Resistance Exercise Therapy to explore the feasibility of introducing such a programme in the bariatric population.
Other: Resistance Exercise Therapy
This group have been randomised to receive standard care post surgery.
4 weeks of Resistance Exercise Therapy. This is a 4 week resistance exercise training programme that can be completed at home. The programme is designed to be progressive. It was designed by a bariatric physiotherapist and an exercise physiologist. This exercise programme will be discussed at the screening visit, educational material will be provided to the participants who are randomised to the intervention RET group. Safety advice will be given to each eligible participant to ensure that if they feel unwell, develop chest pain/tightness, then they must seek advice from GP/urgent care if necessary. The exercises will need to be performed at least three times a week. Compliance will be monitored with Fitbit downloads at each visit. Fitbits will be worn during exercise sessions only.
To assess the effects of bariatric surgery on skeletal muscle ultrasound thickness.
This will be assessed using muscle ultrasound and units (mm)
Time frame: Total duration of study per participant is expected to be 13 to 14 weeks
To assess the effects of bariatric surgery on skeletal muscle cross sectional area (cm2)
This will be assessed using muscle ultrasound
Time frame: Total duration of study per participant is expected to be 13 to 14 weeks
Assessment of percentage of patients who were retained throughout the intervention arm of the study
To be measured as percentage.
Time frame: Total duration of study per participant is expected to be 13 to 14 weeks
Assessment of percentage of patients who were compliant with the intervention arm of the study. To be guided by FitBit monitor use.
This assessment will be measured as percentage of patients who met compliance targets with the intervention arm for the study.
Time frame: Total duration of study per participant is expected to be 13 to 14 weeks
Assessment of number of patients who were recruited to the study
This assessment will be measured as a simple numeric value
Time frame: Total duration of study per participant is expected to be 13 to 14 weeks
Fasting glucose
These results will be undertaken by analysing blood samples taken by venepuncture of participants. Units will be mmol .
Time frame: Total duration of study per participant is expected to be 13 to 14 weeks, there will be bloods taken on each in-person study day. Plan is for 3 of these days, screening bloods will be reviewed from the NHS interface.
Skeletal muscle architecture (fibre length)
An ultrasound scan will be used for the purpose of this measurement. Units (mm).
Time frame: Total duration of study per participant is expected to be 13 to 14 weeks, ultrasounds will be performed at each in-person study day. performed on each in-person study day
Muscle fatigability (maximum voluntary contractions)
This is the maximal force-generating capacity of a muscle or group of muscles
Time frame: Total duration of study per participant is expected to be 13 to 14 weeks, each assessment for this outcome will take place at the in-person study days.
Lean body mass using BIA and D3 creatine
These are stable biomarkers that have been previously used in research. It acts in the body as creatine, which is a naturally occurring substance.
Time frame: Total duration of study per participant is expected to be 13 to 14 weeks, each participant will be provided with the resources to facilitate these assessments at their in-person study days, urine collections will be returned later..
Motor control in force tracking
As part of the Short Physical Performance Battery Test
Time frame: Total duration of study per participant is expected to be 13 to 14 weeks, these assessments will be performed at each in-person study day.
Balance using the Timed Up and Go (TUG) test
As part of the Short Physical Performance Battery Test
Time frame: Total duration of study per participant is expected to be 13 to 14 weeks, these assessments will be performed at each in-person study day.
Balance in Gait and Motion testing
As part of the Short Physical Performance Battery Test
Time frame: Total duration of study per participant is expected to be 13 to 14 weeks, these assessments will be performed at each in-person study day.
Hand grip strength
The purpose of the handgrip strength test is to measure the maximum isometric strength of the hand and forearm muscles
Time frame: Total duration of study per participant is expected to be 13 to 14 weeks, these assessments will be performed at each in-person study day.
Predicted maximum oxygen consumption (VO2 max) in step box test
As part of the Short Physical Performance Battery Test
Time frame: Total duration of study per participant is expected to be 13 to 14 weeks, these assessments will be performed at each in-person study day.
Skin fold and body circumference measurements
To assess for any interval change
Time frame: Total duration of study per participant is expected to be 13 to 14 weeks, these assessments will be performed at each in-person study day.
Quality of life measurements using IPAQ questionnaire
Questionnaires are performed to standardise the assessment of quality of life from the patient perspective. IPAQ questionnaire contains open-ended questions surrounding individuals' last 7-day recall of physical activity
Time frame: Total duration of study per participant is expected to be 13 to 14 weeks, these assessments will be performed at each in-person study day.
insulin resistance (HOMA-IR)
These results will be undertaken by analysing blood samples taken by venepuncture of participants. Units will be nmol/L.
Time frame: Total duration of study per participant is expected to be 13 to 14 weeks, these assessments will be performed at each in-person study day.
Skeletal muscle architecture (pennation angle)
An ultrasound scan will be used for the purpose of this measurement, units will be in degrees.
Time frame: Total duration of study per participant is expected to be 13 to 14 weeks, these assessments will be performed at each in-person study day.
Quality of life measurements using SF-36 questionnaire
Questionnaires are performed to standardise the assessment of quality of life from the patient perspective.This questionnaire uses a likert scale as means of assessment.
Time frame: Total duration of study per participant is expected to be 13 to 14 weeks, these assessments will be performed at each in-person study day.
Plan to share: No — No plan to do so
Started Mar 2023 (actual). Primary completion is estimated for Jun 2024, 15 months after the start.
Of 3,697 non-industry interventional studies with no phase under Obesity, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 43. This study's planned 15 months is below that.
Counting every sponsor, half of 3,861 studies reached it within 22 months; a quarter within 9 and three quarters within 42.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.